Pfizer (PFE) reported second quarter 2021 earnings on Wednesday July 28 before the market opened. Pfizer reported Earnings Per Share (EPS) of $ 1.07 vs. Wall Street analysts’ median estimate of $ 0.96.
The revenue was $ 19 billions versus the median analyst estimate of $ 18.45 billion.
Pfizer also raised its full-year guidance from $ 70,500 – $ 72,500 million to $ 78.8 billion and raises the full-year EPS guidance from $ 3.55 to $ 3.65 to the range of $ 3.95 to $ 4. 05 dollars.
Pfizer raised sales forecasts for the Covid-19 vaccine to $ 33.5 billion from $ 26 billion.
Pfizer Stock Forecast
Pfizer (PFE) shares are trading at $ 42.40 on Wednesday’s premarket, a 0.7% change. Pfizer closed the regular session on Tuesday at $ 42.10, a variation of + 0.69% on Tuesday.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
